Discontinuing Disease-Modifying Therapies in Multiple Sclerosis - Practical Neurology
Symptomatic Management in Multiple Sclerosis - MedLink
Borko TL, Baxter R, Cabrera-Martinez B, Thiruppathi E, Sabalza M, Venkataraman I, Selva S, Rester C, Sillau S, Pastula DM, Bennett JL, Alvarez E, Gross R, Shah A, Kammeyer R, Corboy JR, Kedl RM, Hsieh EWY, Piquet AL. SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients. J Neuroimmunol. 2023 Oct 15;383:578192. PubMed PMID: 37666038
Gnanaraj R, Shah AA, Palestine AG, Reddy AK. Uveitis in the Setting of Co-Existing Systemic Sarcoidosis and Multiple Sclerosis. Ocul Immunol Inflamm. 2023 Jul 19;:1-3. [Epub ahead of print] PubMed PMID: 37467487
Shah AA, Wolf AB, Declusin A, Coleman K, Kammeyer R, Khan B, Corboy JR. Challenging Cases in Neuroimmunology. Semin Neurol. 2022 Dec;42(6):695-707. PubMed PMID: 36690027
Shah AA, Piche J, Stewart B, Lyness C, Callaghan B, Solomon AJ. Limited diagnostic utility of serologic testing for neurologic manifestations of systemic disease in the evaluation of suspected multiple sclerosis: A single-center observational study. Mult Scler Relat Disord. 2023 Jan;69:104443. PubMed PMID: 36521385
Discontinuing Disease-Modifying Therapies in Multiple Sclerosis - Practical Neurology
Kaja S, Hilgenberg JD, Collins JL, Shah AA, Wawro D, Zimmerman S, Magnusson R, Koulen P. Detection of novel biomarkers for ovarian cancer with an optical nanotechnology detection system enabling label-free diagnostics. J Biomed Opt. 2012 Aug;17(8):081412-1. PubMed PMID: 23224173
Kaja S, Shah AA, Haji SA, Patel KB, Naumchuk Y, Zabaneh A, Gerdes BC, Kunjukunju N, Sabates NR, Cassell MA, Lord RK, Pikey KP, Poulose A, Koulen P. Nampt/PBEF/visfatin serum levels: a new biomarker for retinal blood vessel occlusions. Clin Ophthalmol. 2015;9:611-8. PubMed PMID: 25897200